The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpectedly taking the ceo job there sand
The day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpectedly taking the ceo job there sand
Pfizer did turn negative late in the day. The potential tieup is a complicated one, and it puts pfizer in a familiar position. Last year it unsuccessfully pursued astra zeneca, but as meg tirrell reports it now hopes for a different outcome. Reporter pfizer confirmed today its in friendly discussions about a potential combination with irish drug company allergan, the maker of botox. Analysts expect the deal value could total 150 billion. This comes a year and a half after pfizer abandoned its 120 billion bid for astrazeneca. After the british drugmaker resisted its advances in a nasty monthlong battle. Many think allergan will be more willing. The company is led by serial dealmaker brent saunders, who in just two years has amassed almost 150 billion in deal activity. He started at eye Company Bausch lomb where as ceo he sold the company to valeant for almost 9 billion in 2013. Less than a year later at the head of forest labs he engineered a 25 billion sale to activeus. After unexpecte
CHICAGO, IL An all-female group led by Chicago Cubs co-owner Laura Ricketts has closed the sale of the Chicago Red Stars for $60 million a record for an NWSL club. The deal includes $35.5 million paid to the previous ownership group and the remaining $24.5 million being pumped into the club straig
The National Women s Soccer League formally approved the sale of the Chicago Red Stars to an ownership group led by Chicago Cubs co-owner Laura Ricketts.